Everolimus, Cetuximab and Capecitabine in Patients With Metastatic Pancreatic Cancer

The recruitment status of this study is unknown because the information has not been verified recently.

Verified September 2010 by Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA).
Recruitment status was Recruiting

Study NCT01077986 Information provided by Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

First Received on February 25, 2010. Last Updated on September 7, 2010 History of Changes

Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:

Conditions listed in this trial

Additional conditions recognized in this trial

Pancreatic Neoplasms

More general conditions related to this trial

Interventions listed in this trial

Capecitabine
Cetuximab
Everolimus

Additional drug interventions recognized in this trial

Fluorouracil
Sirolimus

More general drug interventions related to this trial

Sponsors listed in this trial